A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: Coexpression of EP1, EP2, EP3β and EP4

Molecular Immunology

Volumn 33, Issue 1, 1996, Pages 33-45

  Fedyk, Eric R ^a   Ripper, John M ^a   Brown, Deborah M ^a   Phipps, Richard P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

B lymphocyte; B lymphoma; EP1; EP2; EP3; EP4; Growth inhibition; LPS; Mouse; Myeloma; PGE; Prostaglandin

Indexed keywords

LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL LINE; GROWTH INHIBITION; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFORMATION; LYMPHOMA CELL; MOUSE; MYELOMA CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALPROSTADIL; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; BUCLADESINE; CELL LINE; DINOPROSTONE; DNA PRIMERS; GENE EXPRESSION; GROWTH INHIBITORS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MISOPROSTOL; MOLECULAR SEQUENCE DATA; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; SPLEEN;

ANIMALIA;

EID: 0029944538     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(95)00130-1     Document Type: Article

References (62)

1. 2 inhibits production of Thllymphokines, but not of Th2 lymphokines. J. Immun. 146, 108-113.
2. 2 receptors on normal and malignant B lymphocytes. Cell. Immun. 161, 79-87.
3. 2 induces apoptosis in immature normal and malignant B lymphocytes. Clin. Immun. Immunopathol. 63, 221-229.
4. 2 enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity. Cell. Immun. 70, 41-54.
5. Chan S. C., Kim J. W., Henderson W. R. and Hanifin J. F., (1993) Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J. Immun. 151, 3345-3352.
6. Chomczynski P. (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15, 532-537
7. Coleman R. A., Smith W. L. and Narumiya S. (1994) International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46, 205-229.
8. Elkashab M. and Lala P. (1991) PGE2 receptors on murine splenic lymphocytes: effects of tumor bearing. Immun. Lett. 30, 7-16.
9. Fedyk E. R. and Phipps R. P. (1994) Reactive oxygen species and not lipoxygenase products are required for mouse B lymphocyte activation and differentiation. Int. J. Immunopharmacol. 16, 533-546.
10. Frey J., Janes M., Engelhardt W., Afting E. G., Geerds C. and Möller B. (1986) Fcgamma-receptor-mediated changes in the plasma membrane potential induce prostaglandin release from human fibroblasts. Eur. J. Biochem. 158, 85-89.
11. Gajewski T. F., Schell S. R. and Fitch F. W. (1990) Evidence implicating utilization of different T cell receptor-associated signaling pathways by Th1 and Th2 clones. J. Immun. 144, 4110-4120.
12. + T lymphoblasts. 154, 1041-1047.
13. Goodwin J. S., Wilk A., Lewis M., Bankhurst A. D. and Williams R. C. Jr (1979) High affinity binding sites for prostaglandin E on human lymphocytes. Cell. Immun. 43, 150-159.
14. Halpern M. S. and Coffman R. L. (1972) Polymer formation and J chain synthesis in mouse plasmacytomas. J. Immun. 109, 674-679.
15. Hanahan D. (1983) Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166(4), 557-580.
16. Harley C. B. (1987) Hybridization of oligo (dT) to RNA on nitrocellulose. Gene Anal. Tech. 4, 17-22.
17. Heinen E., Cormann N., Braun M., Kinet-Dinoël C., Vanderscheiden J. and Simar L. J. (1986) Isolation of follicular dendritic cells from human tonsils and adenoids. Ann. Inst. Past. 137D, 369-382.
18. Hikida M., Takai T. and Ohmori H. (1992) Selective regulation of antigen-specific IgE response by cyclic AMP level in murine lymphocytes. Immun. Lett. 33, 301-306.
19. 2 receptors during human T cell activation. Cell. Immun. 134, 287-295.
20. 2 subtype. J. Biol. Chem. 268, 7759-7762.
21. Irie A., Sugimoto Y., Namba T., Asano T., Ichikawa A. and Negishi M. (1994) The C-terminus of the prostaglandin-E-receptor EP3 subtype is essential for activation of GTP-binding protein. Eur. J. Biochem. 224, 161-166.
22. Irie A., Sugimoto Y., Namba T., Harazono A., Honda A., Watabe A., Negishi M., Narumiya S. and Ichikawa A. (1993) Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur. J. Biochem. 217, 313-318.
23. Jacob T., Huspith B. N., Latchman Y. E., Rycroft, R. and Brostoff, J. (1990) Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin. Exp. Immun. 79, 380-384.
24. Jakobsen K. S., Breivold E. and Homes E. (1990) Purification of mRNA directly from crude plant tissues in 15 minutes using magnetic oligo dt microspheres. Nucleic Acid Res. 18, 3669-3674.
25. Jones D. A., Carlton D. P., McIntyre T. M., Zimmerman G. A. and Prescott S. M. (1993) Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268, 9049-9054.
26. Kovalic D., Kwak J. H. and Weisblum B. (1991) General method for direct cloning of DNA fragments generated by primed enzymatic amplification. Nucleic Acid Res. 19, 4560-4563.
27. Kujubu D. A., Reddy S. T., Fletcher B. S. and Herschman H. R. (1993) Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J. Biol. Chem. 268, 5425-5430.
28. Lee S. H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D. and Hwang D. (1992) Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267, 25934-25938.
29. Leung D. Y. M., Key L., Steinberg J. J., Young M. C., VonDeck M., Wilkinson R. and Geha R. S. (1988) Increased in vitro bone resorption by monocytes in the hyper-immunoglobulin E syndrome. J. Immun. 140, 84-88.
30. Maier J. A. M., Hla T. and Maciag T. (1990) Cyclooxygenase is an immediate early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem. 265, 10805-10808.
31. 2 inhibits the activation of cloned T cell hybridomas. J. Immun. 134, 2645-2650.
32. Munoz E., Zubiaga A. M., Merrow M., Sauter M. P. and Huber B. (1990) Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172, 95-103.
33. Novak T. J. and Rothenberg E. V. (1990) cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. natn. Acad. Sci. USA 87, 9353-9357.
34. O'Banion M. K., Winn V. D. and Young D. A. (1992) cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. natn. Acad. Sci. USA 89, 4888-4892.
35. O'Sullivan M. G., Huggins M. E., Meade M. E. DeWitt D. L. and McCall C. E. (1992). Lipopolysaccharide indices prostaglandin H synthase-2 in aveolar macrophages. Biochem. Biophys. Res. Commun. 187, 1123-1127.
36. Phipps R. P., Lee D., Schad V. and Warner G. L. (1989) E-series prostaglandins are potent growth inhibitors for some B lymphomas. Eur. J. Immun. 19, 995-1001.
37. Phipps R. P., Stein S. H. and Roper R. L. (1991) A new view of prostaglandin E regulation of the immune response. Immun. Today 12, 349-352.
38. Ringden O., Persson U., Johansson S. G. O., Wilczek H., Gahrton G., Lundgren G., Lonnqvist B. and Moller E. (1983) Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood 61, 1190-1195.
39. 2) receptors on atopic T lymphocytes. Cell. Immun. 99, 294-299.
40. 2 promotes B lymphocyte Ig isotype switching to IgE. J. Immun. 154, 162-170.
41. 2 promotes IL-4-induced IgE and IgG1 synthesis. J. Immun. 145, 2644-2651.
42. 2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins. Cell. Immun. 154, 296-308.
43. 2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis. J. Immun. 149, 2984-2991.
44. Sarayan J. A., Rappeport J., Leung D. Y. M., Parkman R. and Geha R. S. (1983) Regulation of human IgE synthesis in acute graft versus host disease. J. Clin. Invest. 71, 556-564.
45. 3 receptor. Prost. Leukotr. Essent. Fatty Acids 49, 939-943.
46. 2. J. Biol. Chem. 254(8), 2914-2917.
47. Scott D. W. (1993) B lymphoma models for tolerance: the good, the bad and the apoptotic. Immunomethods 2, 105-112.
48. Sharma R. K. and Wang J. H. (1986) Regulation of cAMP concentration by calmodulin-dependent cyclic nucleotide phosphodiesterase. Biochem. Cell. Biol. 64, 1072-1080.
49. 1 to rat thymocytes. Biochim. Biophys. Acta 326, 127-133.
50. Siegel A. M., Smith J. B., Silver M. J., Nicolaou K. C. and Ahern D. (1979) Selective binding site for [3H]prostacyclin on platelets. J. Clin. Invest. 63, 215-220.
51. Simmons D. L., Xie W., Chipman J. G. and Evett G. E. (1991) Multiple cyclooxygenases: cloning of a mitogen-inducible form. In Prostaglandins, Leukotrienes, Lipoxins, and PAF (Edited by Bailey, J. M.), pp. 67-78. Plenum Press, New York.
52. a. Ann. N. Y. Acad. Sci. 714, 136-142.
53. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immun. 150, 5321-5329.
54. Stein S. H. and Phipps R. P. (1991) Antigen-specific IgG2a production in response to prostaglandin E2, immune complexes, and IFN-gamma. J. Immun. 147, 2500-2506.
55. 2 and IFN-g. J. Immun. 148, 3943-3949.
56. 3 subtype. J. Biol. Chem. 267, 6463-6466.
57. Sugimoto Y., Namba T., Shigemoto R., Negishi M., Ichikawa A. and Narumiya S. (1994) Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am. J. Physiol. 266, F823-F828.
58. 2 and EP3. Genomics 19, 585-588.
59. Toh H., Ichikawa A. and Narumiya S. (1995) Molecular evolution of receptors for eicosanoids. F.E.B.S. 361, 17-21.
60. van der Pouw-Kraan T. C. T. M., Boeije C. M., Smeenk R. J. T., Wijdenes J. and Aarden L. A. (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181, 775-779.
61. Waldmann T. A., Bull J. M., Bruce R. M., Broder S., Jost M. C., Balestra S. T. and Suer M. E. (1974) Serum immunoglobulin E levels in patients with neoplastic disease. J. Immun. 113, 379-386.
62. 1 sub type of prostaglandin E receptor. J. Biol. Chem. 268, 20175-20178.